Nautilus Biotechnology promotes single molecule proteomics at ASMS with Voyager platform experts

Nautilus Biotechnology promotes single molecule proteomics at ASMS with Voyager platform experts
Nautilus debuts Voyager tech at ASMS

Nautilus Biotechnology is actively presenting its single molecule proteomics enabled by Iterative Mapping on the Nautilus Voyager Platform to attendees at the ASMS conference.

Key team members, Jamie Rose Kuhar, Megan Showalter, and Amber (Kessinger) Faust, are on site to engage with conference participants and share more about the technology. The company aims to demonstrate the capabilities of its Voyager platform in advancing proteomics research.

Earlier this year, Nautilus Biotechnology launched its Voyager Platform at Tau Global 2026, enabling quantification of 768 tau proteoforms, according to a company statement here. The company also presented the Voyager Platform for single-molecule tau proteoform measurement at the same event here. Both introductions focused on applications in precise proteoform analysis.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.